Specifics 1: Head and Neck Cancer and Esophageal Cancer

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Biomarkers in Cancer Therapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-981-13-7295-7_6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• THE OFFICIAL PUBLICATION OF THE INTERNATIONAL ASSOCIATION FOR DENTAL RESEARCH

  2018cited by this paper
• Tumor DNA: an emerging biomarker in head and neck cancer

  2017cited by this paper
• Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches

  2017cited by this paper
• The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

  2017cited by this paper
• Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review

  2017cited by this paper
• The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors

  2017cited by this paper
• ctDNA and cfDNA: Basics and Clinical Relevance

  2017cited by this paper
• Tumour-derived plasma cell-free DNA in patients with head and neck cancer: A short review.

  2017cited by this paper
• Circulating Tumor Cells in Esophageal Cancer

  2017cited by this paper
• CDKN2A methylation in esophageal cancer: a meta-analysis

  2017cited by this paper
• Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery

  2017cited by this paper
• From blood to breath: New horizons for esophageal cancer biomarkers

  2016cited by this paper
• The biology and function of exosomes in cancer.

  2016cited by this paper
• Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry

  2016cited by this paper
• Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.

  2016cited by this paper
• Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma

  2016cited by this paper
• Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence

  2016cited by this paper
• Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis

  2016cited by this paper
• microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer

  2016cited by this paper
• Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

  2016cited by this paper
• Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.

  2016cited by this paper
• Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis

  2015cited by this paper
• Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma

  2015cited by this paper
• Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer

  2015cited by this paper
• Erratum to: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers

  2015cited by this paper
• A Highly Accurate Inclusive Cancer Screening Test Using Caenorhabditis elegans Scent Detection

  2015cited by this paper
• Diagnostic Value of Multiple Tumor Markers for Patients with Esophageal Carcinoma

  2015cited by this paper
• Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review

  2015cited by this paper
• Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma

  2015cited by this paper
• Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.

  2015cited by this paper
• Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: A meta‐analysis

  2015cited by this paper
• Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis

  2015cited by this paper
• Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients

  2015cited by this paper
• NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers

  2015cited by this paper
• Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

  2015cited by this paper
• The MicroRNAs as Prognostic Biomarkers for Survival in Esophageal Cancer: A Meta-Analysis

  2014cited by this paper
• Genomic and molecular characterization of esophageal squamous cell carcinoma

  2014cited by this paper
• Identification of genomic alterations in oesophageal squamous cell cancer

  2014cited by this paper
• Clinical relevance of circulating cell-free microRNAs in cancer

  2014cited by this paper
• Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis

  2014cited by this paper
• Serum autoantibodies in the early detection of esophageal cancer: a systematic review

  2014cited by this paper
• Liquid biopsies: genotyping circulating tumor DNA.

  2014cited by this paper
• Identification of a DNA Methylome Profile of Esophageal Squamous Cell Carcinoma and Potential Plasma Epigenetic Biomarkers for Early Diagnosis

  2014cited by this paper
• High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy

  2014cited by this paper
• The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

  2014cited by this paper
• Epigenetic biomarkers in esophageal cancer.

  2014cited by this paper
• Genetic landscape of esophageal squamous cell carcinoma

  2014cited by this paper
• The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.

  2014cited by this paper
• Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies

  2014cited by this paper
• Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen

  2014cited by this paper
• Clinical impact of serum exosomal microRNA‐21 as a clinical biomarker in human esophageal squamous cell carcinoma

  2013cited by this paper
• Detection of an Extended Human Volatome with Comprehensive Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry

  2013cited by this paper
• Soluble interleukin‐6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy

  2013cited by this paper
• Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer

  2013cited by this paper
• Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

  2013cited by this paper
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

  2013cited by this paper
• A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions

  2013cited by this paper
• Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer.

  2013cited by this paper
• Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus

  2013cited by this paper
• A review of the alterations in DNA methylation in esophageal squamous cell carcinoma

  2013cited by this paper
• Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.

  2012cited by this paper
• Selected ion flow tube-MS analysis of headspace vapor from gastric content for the diagnosis of gastro-esophageal cancer.

  2012cited by this paper
• Potential Diagnostic Value of Serum p53 Antibody for Detecting Esophageal Cancer: A Meta-Analysis

  2012cited by this paper
• DNA repair dysregulation from cancer driver to therapeutic target

  2012cited by this paper
• A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

  2011cited by this paper
• Hypermethylation of multiple tumor-related genes associated with DMNT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma

  2011cited by this paper
• Barrett's esophagus

  2011cited by this paper
• Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis

  2010cited by this paper
• Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

  2010cited by this paper
• Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors

  2010cited by this paper
• Volatile biomarkers in the breath of women with breast cancer

  2010cited by this paper
• Serum autoantibodies as biomarkers for early cancer detection

  2009cited by this paper
• MicroRNA Profiling and Head and Neck Cancer

  2009cited by this paper
• Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.

  2009cited by this paper
• Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case–control study of 569 patients and 879 healthy controls

  2009cited by this paper
• Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling

  2008cited by this paper
• MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.

  2008cited by this paper
• Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

  2008cited by this paper
• Circulating mutant DNA to assess tumor dynamics

  2008cited by this paper
• DNA repair pathways as targets for cancer therapy

  2008cited by this paper
• Autoantibodies to tumor‐associated antigens: reporters from the immune system

  2008cited by this paper
• Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

  2008cited by this paper
• MicroRNA alterations in head and neck squamous cell carcinoma

  2008cited by this paper
• miR-21-mediated tumor growth

  2007cited by this paper
• p53 Gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: Results in Japan and comparisons with other countries

  2007cited by this paper
• Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

  2007cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• Prediction of lung cancer using volatile biomarkers in breath

  2005cited by this paper
• The sentinel within: exploiting the immune system for cancer biomarkers.

  2005cited by this paper
• Detection and quantification of mutations in the plasma of patients with colorectal tumors.

  2005cited by this paper
• Identification of hundreds of conserved and nonconserved human microRNAs

  2005cited by this paper
• Prediction of mammalian microRNA targets.

  2003cited by this paper
• Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma.

  2003cited by this paper
• Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.

  2003cited by this paper
• Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma.

  2002cited by this paper
• Sodium thiosulfate solution spray for relief of irritation caused by Lugol's stain in chromoendoscopy.

  2001cited by this paper
• Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

  2001cited by this paper
• Detection of circulating tumor cells and micrometastases in Stage II, III, and IV breast cancer patients utilizing cytology and immunocytochemistry

  2000cited by this paper

• No citing papers are available for this paper.